Sign In
Buy ATNM
$0.84
-0.0001 (-0.0119%)
At Close: Jul 31, 2026
NEW YORK , May 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM) of a class action securities lawsuit. CLAS
Securities Class Action Lawsuit Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - Levi & Korsinsky Represents Shareholders
03:15pm, Thursday, 15'th May 2025
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Lawsuit – ATNM
01:43pm, Thursday, 15'th May 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Actinium Pharmaceuticals, Inc. (ATNM)
12:15pm, Thursday, 15'th May 2025
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) between
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025 - Contact Levi & Korsinsky
10:45am, Thursday, 15'th May 2025
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
Investors Urged to Contact Levi & Korsinsky for Information Before May 27, 2025 - Actinium Pharmaceuticals, Inc. (ATNM)
07:15am, Thursday, 15'th May 2025
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Actiniu
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - May 27, 2025 Deadline to Join - Contact The Gross Law Firm
05:45am, Thursday, 15'th May 2025
NEW YORK , May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. (NYSE: ATNM). Shareholders who purchased shares of ATNM during
Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM) - Join by May 27, 2025 - Contact Levi & Korsinsky
09:20pm, Wednesday, 14'th May 2025
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm
03:28pm, Wednesday, 14'th May 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) br
May 27, 2025 Deadline: Join Class Action Lawsuit Against Actinium Pharmaceuticals, Inc. (ATNM) - Contact Levi & Korsinsky
03:15pm, Wednesday, 14'th May 2025
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / WHY: New York, N.Y., May 14, 2025.
Actinium Pharmaceuticals, Inc. (ATNM) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of May 27, 2025 Deadline
01:45pm, Wednesday, 14'th May 2025
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
01:26pm, Wednesday, 14'th May 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Actinium To Contact Him Directly To Discuss Their Options
